Six readers
| reader | found | score |
|---|---|---|
| genetics Open Targets | no genetic evidence; overall 0.08 from other evidence | 0.00 |
| cell type Human Protein Atlas | expressed broadly, no clear home in brain cells | 0.40 |
| chemistry Open Targets | reachable by antibody | 0.45 |
| trials ClinicalTrials.gov | no Parkinson's trials on record: an open field | 1.00 |
| literature PubMed | 3 Parkinson's papers of 169 | 0.82 |
| pathways Reactome | 16 pathways; mostly protein handling | 0.90 |
No case: the score is under the bar. Receipt 3468
Sealed predictions
- GPC4 in dopamine neurons, braak+0.26 (p 0.502) → -0.17 (p 0.666)receipt 3475
Swarm cases
receipt 3475: GPC4 in dopamine neurons, braak
- power
- full sample +0.01 (p 0.962, n 18), 95% CI -0.46 to +0.48. the interval is wide: not enough donors to tell.
- confounder
- adjusted for sex: -0.10 (p 0.696, n 18). does not hold up.
- composition
- dopamine neurons share of nuclei vs axis +0.05 (p 0.854); controlling for it: -0.19 (p 0.439, n 18). could be the mix.
- skeptic
- leave-one-out range -0.14 to +0.15, sign flips 6; without severely affected donors +0.01 (p 0.962, n 18). fragile.
- cell type
- no other cell group does better.
- axis
- no measure beats "tracks Braak Lewy-body stage" for GPC4 in dopamine neurons.
case closed: nothing better to follow up.
Receipts
loading the receipts